About Us

Our commitment to holistic health and wellness is at the forefront of everything we do. Our practice offers comprehensive services designed to address your unique health needs and goals. From advanced pain management techniques and hormone treatment therapies to osteopathic medicine, cutting-edge anti-aging solutions, and traditional acupuncture, our expert team employs an integrative approach to health care. Combining the latest medical advancements with time-honored treatments, we strive to provide personalized care that supports your journey toward optimal health and vitality. At North Jersey Integrated Medicine, we believe in treating the whole person, not just the symptoms, ensuring a balanced and healthy life for all our patients.

Michael Dobrow, D.O. - North Jersey Integrated Medicine

Michael Dobrow, D.O.

Dr. Dobrow holds board certifications in Pain Medicine, Family Medicine, and Osteopathic Medicine, showcasing his comprehensive expertise in managing and treating pain. He embarked on his medical journey at Rutgers University, where he completed his undergraduate studies. Dr. Dobrow attained his D.O. (Doctor of Osteopathic Medicine) degree from the New York College of Osteopathic Medicine. His postgraduate training includes a residency affiliated with the University of Medicine and Dentistry of New Jersey, where he further honed his skills.

Dr. Dobrow adopts an integrated treatment approach to address pain, combining his specialized knowledge in osteopathy with hands-on manipulation techniques. These techniques are adept at alleviating various conditions, from headaches to back pain. His proficiency extends to performing Osteopathic Manipulation and various procedures, including EMGs, PRP (Platelet-Rich Plasma therapy), Regenerative Medicine, sacroiliac joint injections, epidural injections, facet joint injections, and other joint and trigger point injections.

Outside of his professional life, Dr. Dobrow is passionate about spending quality time with his family and engaging in activities like traveling, running, and practicing Brazilian jiu-jitsu and Muay Thai. These interests reflect his commitment to maintaining a balanced and healthy lifestyle, mirroring the holistic health principles he advocates for his patients.

Lisa Fuh, D.O. - North Jersey Integrated Medicine

Lisa Fuh, D.O.

Lisa Fuh D.O. was born in Taiwan and moved to New Jersey when she was 9 years old. Her academic journey culminated in a Bachelor of Science in Biochemistry with a minor in Spanish from Rutgers, The State University of New Jersey. She further honed her medical expertise at the University of Medicine and Dentistry of New Jersey (UMDNJ), where she also completed her residency in family medicine. During her residency at a UMDNJ-affiliated hospital, she concentrated on women's health, addressing diseases and challenges unique to this demographic.

The personal challenge of undergoing IVF profoundly influenced Lisa, igniting a fervent desire to support others on their path to parenthood. This passion and her deep insight into women's health naturally led her to North Jersey Integrated Medicine. As both a physician and a mother, Lisa is deeply committed to aiding her patients on their health journeys.

When not at work, Lisa cherishes time with her family, frequently organizing trips around the globe, with a particular fondness for Disney World. Her hobbies include yoga, participating in local races, and playing the violin. Lisa is bilingual and fluent in both Mandarin and English.


Clinical Publications

Juif, P.-E., Boehler, M., Dobrow, M., Ufer, M., & Dingemanse, J. (2019). Clinical pharmacology of the reversible and potent P2Y12 receptor antagonist ACT-246475 after single subcutaneous administration in healthy male subjects. Journal of Clinical Pharmacology, 59(1), 123-130. https://doi.org/10.1002/jcph.1296

Schilling, U., Dingemanse, J., Dobrow, M., Baumann, M., Riederer, M. A., Juif, P.-E., & Ufer, M. (2021). Insights from in vitro and clinical data to guide transition from the novel P2Y12 antagonist Selatogrel to clopidogrel, prasugrel, and ticagrelor. Thrombosis and Haemostasis, 121(6), 755-766. https://doi.org/10.1055/s-0040-1721773